Structure Therapeutics (GPCR) Assets Average (2023 - 2026)

Structure Therapeutics' Assets Average history runs 4 years deep, the most recent figure standing at $1.5 billion for Q1 2026.

• In Q1 2026, Assets Average rose 74.7% year-over-year to $1.5 billion; the TTM figure through Mar 2026 stood at $1.5 billion (up 74.7% YoY), while the FY2025 annual figure was $1.2 billion, up 79.54% from the prior year.
• Assets Average was $1.5 billion for Q1 2026 at Structure Therapeutics, up from $1.2 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.5 billion in Q1 2026 to a low of $172.6 million in Q1 2023.
• Historically, Assets Average has averaged $716.8 million across 4 years, with a median of $824.3 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Assets Average soared 321.77% in 2024, then declined 12.32% in 2025.
• A 4-year view of Assets Average shows it stood at $349.2 million in 2023, then soared by 162.97% to $918.3 million in 2024, then jumped by 31.56% to $1.2 billion in 2025, then climbed by 27.98% to $1.5 billion in 2026.
• The last three Assets Average figures came in at $1.5 billion (Q1 2026), $1.2 billion (Q4 2025), and $824.3 million (Q3 2025), per Business Quant data.